Keith A. Otto

Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis

Guoqing Cao, Liang Yu, Carol L. Broderick et al. · Journal of Biological Chemistry · 2003 · 291 citations · Full text

Liver X Receptor, Insulin Signaling, Oxidative Stress +22

Molecular determinants of FGF‐21 activity—synergy and cross‐talk with PPARγ signaling

Julie S. Moyers, Tatiyana L. Shiyanova, Farrokh Mehrbod et al. · Journal of Cellular Physiology · 2006 · 184 citations · Full text

Metabolic Remodeling, Insulin Signaling, Obesity +19

Deficiency of Adiponectin Receptor 2 Reduces Diet-Induced Insulin Resistance but Promotes Type 2 Diabetes

Yanfang Liu, M. Dodson Michael, Shera Kash et al. · Endocrinology · 2006 · 114 citations

Structural basis for GPR40 allosteric agonism and incretin stimulation

Joseph D. Ho, Betty Chau, Logan Rodgers et al. · Nature Communications · 2018 · 85 citations · Full text

A Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist with a Unique in Vitro Profile and Potent Glucose and Lipid Effects in Rodent Models of Type 2 Diabetes and Dyslipidemia

Anne Reifel‐Miller, Keith A. Otto, Eric D. Hawkins et al. · Molecular Endocrinology · 2005 · 64 citations · Full text

Insulin Signaling, Metabolic Syndrome, Metabolic Signaling +17